Document is current
Any future updates will be listed below
-
Authors
Ottema, Sophie
Mulet-Lazaro, Roger http://orcid.org/0000-0003-0298-7948
Erpelinck-Verschueren, Claudia http://orcid.org/0000-0002-3965-4488
van Herk, Stanley http://orcid.org/0000-0002-8707-703X
Havermans, Marije
Arricibita Varea, Andrea
Vermeulen, Michael
Beverloo, H. Berna
Gröschel, Stefan
Haferlach, Torsten
Haferlach, Claudia
J. Wouters, Bas
Bindels, Eric
Smeenk, Leonie http://orcid.org/0000-0001-7025-8515
Delwel, Ruud
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (EMCR 2015-7935)
- License Information
-
More Information
Article History
Received: 10 June 2021
Accepted: 2 September 2021
First Online: 28 September 2021
Competing interests
: T.H. and C.H. are employees of and have equity ownership in MLL Munich Leukemia Laboratory. The remaining authors declare no competing interests.
